WCG Acquires PharmaSeek to Expand Clinical Management Services Network

On August 8, 2019, VCBeat (WeChat ID: vcbeat) learned that WCG (WIRB-Copernicus Group) had acquired the clinical services company PharmaSeek; specific transaction details were not disclosed.

Following this acquisition, PharmaSeek will continue to operate independently and retain its headquarters in Wisconsin, USA. WCG will provide PharmaSeek with capital, expertise, and corporate operational support.

Headquartered in Wisconsin, USA, PharmaSeek is dedicated to providing management, consulting, and training services to CROs and clinical research organizations. By enhancing administrative efficiency to accelerate study start-up times for clients, the company helps reduce clinical research expenditures and enables research institutions to devote more time to developing new therapies for patients. To date, PharmaSeek has been serving a wide range of research institutions as an agent for over 25 years.

Dr. Nicolas Cindric, CEO of PharmaSeek, stated, “We are delighted to join WCG, an organization dedicated to reducing the cost of drug development. This collaboration is not a traditional acquisition; rather, we feel as though we have received an exclusive invitation to join a community of like-minded professionals. Through this transaction, we are able to deliver greater value in the field of clinical services. Patients need access to top-tier physicians and cutting-edge treatments, yet one of the biggest challenges facing many of our major clients is attracting leading talent in therapeutic areas. We guide our clients on talent acquisition and commercial strategy layout, while providing administrative support to optimize their management.”

WCG (WIRB-Copernicus Group), founded in 2012 and headquartered in New Jersey, USA, is the healthcare industry’s first Clinical Services Organization (CSO). It is dedicated to providing high-quality services to clinical trial sites to accelerate advances in human health sciences. WCG has established a standardized clinical service system that significantly enhances research efficiency for CROs, pharmaceutical companies, and clinical research institutions.

Dr. Donald A. Deieso, Executive Chairman and Chief Executive Officer of WCG, stated, “We are proud to provide researchers with best-in-class clinical management solutions to optimize their clinical trials. PharmaSeek is an organization dedicated to enhancing the efficiency of clinical research. We look forward to expanding PharmaSeek’s reach and providing stronger support to research institutions.”

Dr. Jonathan Zung, Executive Vice President of WCG’s Site Division, stated, “We have been committed to expanding WCG’s Global Research Network (GRN), which now comprises more than 2,800 partner institutions. The addition of PharmaSeek will diversify the voices within our site community, thereby enabling us to deliver higher-quality services to our partners.”

(Compiled by Hu Yifan)